Publicaciones en las que colabora con Josefa Castillo Aliaga (12)

2010

  1. Impairment of pre-mRNA splicing in liver disease: Mechanisms and consequences

    World Journal of Gastroenterology, Vol. 16, Núm. 25, pp. 3091-3102

2009

  1. Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform ΔEx2p73 in Human Hepatocellular Tumors

    Gastroenterology, Vol. 137, Núm. 5

  2. Inflammation and liver cancer: New molecular links

    Annals of the New York Academy of Sciences

  3. The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression

    Journal of Hepatology, Vol. 51, Núm. 6, pp. 1010-1020

  4. The epidermal growth factor receptor: A link between inflammation and liver cancer

    Experimental Biology and Medicine

  5. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy

    Cancer Research, Vol. 69, Núm. 4, pp. 1358-1367

2008

  1. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis

    Hepatology, Vol. 48, Núm. 4, pp. 1251-1261

2007

  1. Amphiregulin: A new growth factor in hepatocarcinogenesis

    Cancer Letters, Vol. 254, Núm. 1, pp. 30-41

  2. New molecular targets for hepatocellular carcinoma: The ErbB1 signaling system

    Liver International, Vol. 27, Núm. 2, pp. 174-185

2006

  1. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells

    Cancer Research, Vol. 66, Núm. 12, pp. 6129-6138

2005

  1. Amphiregulin: An early trigger of liver regeneration in mice

    Gastroenterology, Vol. 128, Núm. 2, pp. 424-432

  2. Novel role for amphiregulin in protection from liver injury

    Journal of Biological Chemistry, Vol. 280, Núm. 19, pp. 19012-19020